Polycystic ovary syndrome (PCOS), a chronic hormonal condition that impacts one in 10 Canadian women, is being renamed to polyendocrine metabolic ovarian syndrome (PMOS).

The announcement was published in the Lancet, which states that the condition affects 170 million women during their reproductive years alone.

The condition can cause a range of symptoms, such as irregular or disrupted menstrual cycles, infertility, excessive facial hair and mental health issues, and “has multisystem health impacts and represents a growing health and economic burden.”